Understanding how lack of water affects HIV treatment outcomes
Identifying the mechanisms of water insecurity on HIV treatment outcomes
This study looks at how not having enough safe water affects the health and treatment of people living with HIV in Ghana, focusing on how it can cause stress and make it harder for them to stick to their treatment plans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11077151 on NIH RePORTER |
What this research studies
This research investigates the impact of water insecurity on the health and treatment outcomes of individuals living with HIV in sub-Saharan Africa, particularly in Ghana. It explores how the lack of access to safe water can lead to emotional distress, increased anxiety, and disruptions in healthcare engagement, which may negatively affect adherence to HIV treatment. The study aims to identify the pathways through which water insecurity influences both mental and physical health, ultimately affecting the management of HIV. By analyzing these factors, the research seeks to provide insights that could improve health outcomes for people living with HIV in vulnerable regions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV in sub-Saharan Africa, particularly those experiencing water insecurity.
Not a fit: Patients living with HIV who have stable access to safe water and are not affected by water insecurity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing HIV treatment in areas affected by water insecurity, enhancing patient health outcomes.
How similar studies have performed: While the specific focus on water insecurity and HIV treatment outcomes may be novel, related research has shown that environmental factors significantly impact health outcomes in vulnerable populations.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Ouner, Jerry John — University of California, San Francisco
- Study coordinator: Ouner, Jerry John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.